UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
UTAH MEDICAL PRODUCTS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$74.55+0.04 (+0.05%)
Close on Oct 19, 2026
- Market cap
- $237.37M
- P/E (TTM)
- 22.7
- Dividend yield
- –
Share price
+$15.11 (+25.42%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
UTAH MEDICAL PRODUCTS INC reported revenue of $36.11M for the twelve months to Jun 30, 2026. Free cash flow was $11.45M.
Revenue
$36.11M
TTM Q2 2026
Operating income
$10.27M
TTM Q2 2026
Free cash flow
$11.45M
TTM Q2 2026
EPS, diluted
$3.28
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $237.37M
- P/E ratio
- 22.7
- Price to sales
- 6.57
- Price to book
- 1.95
- Dividend yield
- –
- Free cash flow yield
- 4.82%
Fundamentals
- Revenue
- $36.11M
- EPS, diluted
- $3.28
- Free cash flow
- $11.45M
- Book value per share
- $38.33
- Diluted shares
- 3M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$36.11M
Gross profit
$20.91M
Operating income
$10.27M
EPS, diluted
$3.28
Free cash flow
$11.45M
Reported periodTrailing twelve months